Top 10 Companies in the Global Methyl 2-Bromooctanoate Market (2026): Market Leaders Powering Global Chemical Synthesis

MARKET INSIGHTS

Global Methyl 2-Bromooctanoate market size was valued at USD 31.5 million in 2025. The market is projected to grow from USD 33.2 million in 2026 to USD 48.7 million by 2034, exhibiting a CAGR of 4.9% during the forecast period.

Methyl 2-Bromooctanoate is a crucial organic ester and alkylating agent characterized by the molecular formula C9H17BrO2. This compound serves as a versatile chemical intermediate in advanced organic synthesis. Its primary applications involve its use as a key building block for constructing more complex molecules, particularly in the pharmaceutical sector for active pharmaceutical ingredient (API) development and in the fine chemicals industry for producing high-value fragrance components.

The market growth is primarily driven by the consistent demand from the pharmaceutical industry, where the compound is used in synthesizing various therapeutic agents. Furthermore, the expanding personal care and cosmetics industry fuels demand for novel fragrance ingredients. However, the market faces challenges such as stringent environmental regulations governing brominated compounds and supply chain volatility for raw materials. Key players like BLD Pharm, Actylis, and CAPOT Chemical are focusing on expanding their production capacities and ensuring high‑purity grades to cater to the evolving needs of end‑use industries.

Global Methyl 2-Bromooctanoate Market – View in Detailed Research Report

Top 10 Companies

1️⃣ BLD Pharm

Headquarters: Shanghai, China
Key Offering: High‑purity Methyl 2‑Bromooctanoate for pharmaceutical intermediates

BLD Pharm has rapidly expanded its production capacity with state‑of‑the‑art bromination facilities, positioning itself as a trusted supplier for global pharmaceutical manufacturers. The company emphasizes stringent quality control and GMP compliance, ensuring consistent batch performance for API development.

Sustainability & Growth Initiatives:

• Investing in catalytic bromination to reduce hazardous waste.
• Partnerships with research institutions for green chemistry innovations.
• Expansion of high‑purity (>99%) grades to meet stringent regulatory requirements.

2️⃣ Shanghai Theorem Chemical Technology Co., Ltd.

Headquarters: Shanghai, China
Key Offering: Specialty Methyl 2‑Bromooctanoate for fine chemicals and fragrance synthesis

Theorem leverages proprietary purification technologies to deliver ultra‑pure intermediates that enable complex fragrance molecules and high‑value specialty chemicals. Their integrated supply chain ensures rapid turnaround for time‑critical projects.

Sustainability & Growth Initiatives:

• Implementation of continuous‑flow reactors to enhance process efficiency.
• Adoption of renewable energy sources across production sites.
• Development of eco‑friendly solvent recycling systems.

3️⃣ Actylis

Headquarters: Paris, France
Key Offering: Specialty API intermediates and chiral synthesis support

Actylis focuses on delivering high‑purity Methyl 2‑Bromooctanoate for pharmaceutical R&D, particularly in chiral drug synthesis. Their expertise in stereoselective transformations makes them a preferred partner for pharma companies seeking innovative drug candidates.

Sustainability & Growth Initiatives:

• Investment in green chemistry protocols to minimize halogen waste.
• Collaborations with European universities for advanced synthesis research.
• Commitment to ISO 14001 environmental management.

4️⃣ eMolecules

Headquarters: San Diego, USA
Key Offering: Custom synthesis and contract manufacturing of Methyl 2‑Bromooctanoate

eMolecules serves the research and development community with tailored synthesis routes, offering flexibility for small‑scale and pilot projects. Their agile production lines cater to niche applications such as biocides and specialty fragrance intermediates.

Sustainability & Growth Initiatives:

• Adoption of modular, energy‑efficient reactors.
• Use of biodegradable solvents in certain processes.
• Engagement in industry forums on sustainable bromination.

5️⃣ Linshu Huashenf Chemical Co. Ltd.

Headquarters: Shenzhen, China
Key Offering: High‑yield catalytic bromination for cost‑effective production

Linshu Huashenf focuses on scalable catalytic processes that reduce raw‑material consumption and lower production costs, making it an attractive partner for start‑up pharma companies seeking affordable intermediates.

Sustainability & Growth Initiatives:

• Implementation of waste‑minimization protocols.
• Partnerships with local universities for process optimization.
• Investment in waste‑to‑energy conversion systems.

6️⃣ Wuhan Xiju Biotechnology Co., Ltd.

Headquarters: Wuhan, China
Key Offering: Advanced biochemical applications of Methyl 2‑Bromooctanoate

Wuhan Xiju integrates biocatalysis with traditional bromination to create versatile intermediates for both pharmaceutical and agrochemical sectors. Their dual‑mode approach enhances product versatility.

Sustainability & Growth Initiatives:

• Research into enzyme‑mediated bromination.
• Deployment of closed‑loop water systems.
• Collaborations with biotech firms for green synthesis.

7️⃣ Finetech Industry Limited

Headquarters: Boston, USA
Key Offering: Fine‑chemical grade Methyl 2‑Bromooctanoate for fragrance synthesis

Finetech delivers high‑purity intermediates tailored for fragrance chemists, enabling the creation of complex scent profiles. Their rigorous quality assurance processes meet the strict standards of the fragrance industry.

Sustainability & Growth Initiatives:

• Investment in renewable feedstock sourcing.
• Development of low‑VOC solvent alternatives.
• Participation in global fragrance sustainability initiatives.

8️⃣ BOC Sciences

Headquarters: San Francisco, USA
Key Offering: Custom synthesis and specialty chemical solutions

BOC Sciences offers bespoke production services for niche applications, including chiral drug intermediates and specialty agrochemicals. Their flexible manufacturing capabilities cater to evolving market needs.

Sustainability & Growth Initiatives:

• Implementation of digital twins for process optimization.
• Use of AI‑driven predictive maintenance.
• Commitment to carbon‑neutral operations by 2030.

9️⃣ Sinfoo Biotech

Headquarters: Chengdu, China
Key Offering: Catalytic bromination for high‑value intermediates

Sinfoo Biotech focuses on catalytic methods that increase yield while reducing hazardous waste. Their technology is particularly suited for high‑purity API production.

Sustainability & Growth Initiatives:

• Development of catalyst recycling protocols.
• Partnerships with academic research labs.
• Investment in green chemistry certification.

🔟 Yancheng Longsheng Chemical Co., Ltd.

Headquarters: Yancheng, China
Key Offering: Bulk production of Methyl 2‑Bromooctanoate for agrochemical and fine‑chemical markets

Longsheng Chemical supplies large volumes of Methyl 2‑Bromooctanoate to agrochemical manufacturers, supporting the development of advanced herbicides and fungicides. Their scale‑up capabilities ensure timely delivery to global customers.

Sustainability & Growth Initiatives:

• Adoption of energy‑efficient production lines.
• Implementation of water‑recycling systems.
• Commitment to reducing CO₂ emissions by 25% by 2030.

---

Download FREE Sample Report: Global Methyl 2-Bromooctanoate Market – View in Detailed Research Report

Get Full Report: Global Methyl 2-Bromooctanoate Market – View in Detailed Research Report

Outlook

The Global Methyl 2‑Bromooctanoate market is projected to experience steady growth, driven by expanding pharmaceutical R&D pipelines and increasing demand for high‑purity fragrance intermediates. With a CAGR of 4.9% from 2026 to 2034, the market is expected to reach USD 48.7 million by 2034, reflecting a robust expansion in both North American and Asia‑Pacific regions.

Future Trends

• High‑Purity (>99%) Demand: Industries increasingly require ultra‑pure intermediates to meet stringent regulatory and performance standards.
• Sustainable Bromination: Adoption of catalytic and flow‑chemistry processes to reduce hazardous waste and improve environmental profiles.
• Digitalization & Automation: Implementation of AI, digital twins, and real‑time analytics to optimize reaction pathways and reduce operational costs.
• Regional Expansion: Asia‑Pacific is emerging as the fastest‑growing market, driven by large‑scale pharmaceutical manufacturing and fragrance production.
• Regulatory Alignment: Harmonization of safety and environmental regulations across major markets, encouraging global compliance strategies.